These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9879413)

  • 1. Suppression of seasonal increase in serum interleukin-5 is linked to the clinical efficacy of immunotherapy for seasonal allergic rhinitis.
    Hayashi M; Ohashi Y; Tanaka A; Kakinoki Y; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():133-42. PubMed ID: 9879413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of specific IgE, soluble interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in seasonal allergic rhinitis.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Ohno Y; Masamoto T; Sakamoto H; Kato A; Washio Y; Hayashi M
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):213-20. PubMed ID: 9305226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy affects the seasonal increase in specific IgE and interleukin-4 in serum of patients with seasonal allergic rhinitis.
    Ohashi Y; Nakai Y; Kakinoki Y; Ohno Y; Tanaka A; Masamoto T; Sakamoto H; Washio Y; Kato A
    Scand J Immunol; 1997 Jul; 46(1):67-77. PubMed ID: 9246210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonal changes in phytohemagglutinin-induced cytokine synthesis by peripheral blood lymphocytes of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
    Tsuda M; Ohashi Y; Washio Y; Kakinoki Y; Nakai Y; Tanaka A; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():156-68. PubMed ID: 9879416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen induced mRNA expression of interleukin-5, but not of interleukin-4 and interferon-gamma, in peripheral blood mononuclear cells obtained before the pollen season predicts the clinical efficacy of immunotherapy for seasonal allergic rhinitis.
    Kakinoki Y; Ohashi Y; Nakai Y; Washio Y; Nasako Y; Tanaka A; Nakai Y
    Scand J Immunol; 2000 Feb; 51(2):202-8. PubMed ID: 10652165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum level of soluble interleukin-2 receptor in patients with seasonal allergic rhinitis.
    Ohashi Y; Tanaka A; Kakinoki Y; Ohno Y; Sakamoto H; Kato A; Masamoto T; Wahio Y; Nakai Y
    Scand J Immunol; 1997 Mar; 45(3):315-21. PubMed ID: 9122623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
    Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
    Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific immunoglobulin E, interleukin-4, and soluble vascular cell adhesion molecule-1 in sera in patients with seasonal allergic rhinitis.
    Masamoto T; Ohashi Y; Nakai Y
    Ann Otol Rhinol Laryngol; 1999 Feb; 108(2):169-76. PubMed ID: 10030236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal rise in interleukin-4 during pollen season is related to seasonal rise in specific IgE for pollens but not for mites.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Ohno Y; Sakamoto H; Kato A; Masamoto T; Washio Y; Yamada K
    Acta Otolaryngol; 1998 Mar; 118(2):243-7. PubMed ID: 9583794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of immunotherapy on seasonal changes in serum-specific IgE and IgG4 in patients with pollen allergic rhinitis.
    Ohashi Y; Tanaka A; Kakinoki Y; Ohno Y; Sakamoto H; Kato A; Masamoto T; Washio Y; Nakai Y
    Laryngoscope; 1997 Sep; 107(9):1270-5. PubMed ID: 9292616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy decreases seasonal rise in serum-soluble CD23 in seasonal allergic rhinitis.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Ohno Y; Masamoto T; Sakamoto H; Kato A; Washio Y; Hayashi M
    Laryngoscope; 1998 May; 108(5):706-11. PubMed ID: 9591550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical role of specific IgE and IgG4 antibodies in patients having immunotherapy for seasonal allergic rhinitis.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Masamoto T; Kato A; Sakamoto H
    Clin Otolaryngol Allied Sci; 1998 Apr; 23(2):128-35. PubMed ID: 9597282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergen-induced synthesis of interleukin-5, but not of IgE, is a key mechanism linked to symptomatic episodes of seasonal allergic rhinitis in sensitized individuals.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Masamoto T; Kato A; Washio Y; Yamada K; Hayashi M; Ohmoto Y
    Scand J Immunol; 1998 Jun; 47(6):596-602. PubMed ID: 9652829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and immunologic changes after allergen immunotherapy with Hop Japanese pollen.
    Park HS; Nahm DH; Kim HY; Suh YJ; Cho JW; Kim SS; Lee SK; Jung KS
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):444-8. PubMed ID: 11345290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal increase in specific IgE in serum induced by natural Japanese cedar pollen exposure in asymptomatic and symptomatic sensitized individuals.
    Kakinoki Y; Ohashi Y; Kato A; Tanaka A; Washio Y; Yamada K; Masamoto T; Nasako Y; Nakai Y; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():152-5. PubMed ID: 9879415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cc-chemokine eotaxin as a marker of efficacy of specific immunotherapy in patients with intermittent IgE-mediated allergic rhinoconjunctivitis.
    Jahnz-Rózyk K; Targowski T; Głodzinska-Wyszogrodzka E; Płusa T
    Allergy; 2003 Jul; 58(7):595-601. PubMed ID: 12823117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pollen immunotherapy inhibits T helper 1 and 2 cell responses, but suppression of T helper 2 cell response is a more important mechanism related to the clinical efficacy.
    Kakinoki Y; Ohashi Y; Nakai Y; Tanaka A; Washio Y
    Arch Otolaryngol Head Neck Surg; 2000 Jan; 126(1):63-70. PubMed ID: 10628713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial.
    Chaker AM; Shamji MH; Dumitru FA; Calderon MA; Scadding GW; Makatsori M; Jones I; He QA; Subramanian KK; Arm JP; Durham SR; Schmidt-Weber CB
    J Allergy Clin Immunol; 2016 Feb; 137(2):452-461.e9. PubMed ID: 26531865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis.
    Kuehr J; Brauburger J; Zielen S; Schauer U; Kamin W; Von Berg A; Leupold W; Bergmann KC; Rolinck-Werninghaus C; Gräve M; Hultsch T; Wahn U
    J Allergy Clin Immunol; 2002 Feb; 109(2):274-80. PubMed ID: 11842297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.